Lipella Pharmaceuticals Stock (NASDAQ: LIPO) stock price, news, charts, stock research, profile.
Open | $0.47 |
Close | - |
Volume / Avg. | 11.84K / 41.12K |
Day Range | 0.46 - 0.48 |
52 Wk Range | 0.40 - 2.71 |
Market Cap | $3.57M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 0.25% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lipella Pharmaceuticals (NASDAQ:LIPO) through any online brokerage.
Other companies in Lipella Pharmaceuticals’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO) and Quoin Pharmaceuticals (NASDAQ:QNRX).
There is no analysis for Lipella Pharmaceuticals.
Lipella Pharmaceuticals has a consensus price target of $2.00.
The stock price for Lipella Pharmaceuticals (NASDAQ: LIPO) is $0.4591 last updated Today at July 17, 2024 at 12:49 PM EDT.
There are no upcoming dividends for Lipella Pharmaceuticals.
Lipella Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Lipella Pharmaceuticals.
Lipella Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.